Effects of 1,25 (OH)2 0 3 Treatment on Lipid Levels in Uremic Hemodialysis Patients

Basit Öğe Kaydı
dc.contributor.authorYeksan, M.
dc.contributor.authorTürk, S.
dc.contributor.authorPolat, M.
dc.contributor.authorÇığlı, A.
dc.contributor.authorErdoğan, Y.
dc.date.accessioned2020-03-26T16:24:16Z
dc.date.available2020-03-26T16:24:16Z
dc.date.issued1992
dc.departmentSelçuk Üniversitesien_US
dc.description.abstractThe aim of this study was to evaluate the effect of 1,25 (OH)2D3 treatment on lipid levels in uremic hemodialysis (HD) patients. Thirty-one HD patients who had never been treated with vitamin D nor related drugs and 12 healthy subjects with normal renal functions were studied. Uremic HD patients were randomly divided into two groups. Sixteen uremic HD patients were treated with oral calcitriol (0.5 mug/day) for 8 weeks. 13 uremic HD patients and 12 healthy subjects were given placebo. In all these cases before and after 8 weeks of treatments; serum total lipid, total cholesterol, HDL-cholesterol, LDL-cholesterol and triglycerid levels were determined. After calcitriol treatment, triglycerid levels were significantly decreased. But total lipid, cholesterol, HDL-cholesterol and LDL-cholesterol levels did not significantly change. In the other two groups there were no significant changes. These results show that calcitriol treatment has a positive effect on triglycerid levels in uremic HD patients. This effect of mechanism of calcitriol treatment has not been known yet. But it could be due to regulation carbohydrates metabolism and normalization of parathormone (PTH) levels.en_US
dc.identifier.citationYeksan, M., Türk, S., Polat, M., Çığlı, A., Erdoğan, Y., (1992). Effects of 1,25 (OH)2 0 3 Treatment on Lipid Levels in Uremic Hemodialysis Patients. The International Journal of Artificial Organ, 15(12), 704-707.
dc.identifier.endpage707en_US
dc.identifier.issn0391-3988en_US
dc.identifier.issn1724-6040en_US
dc.identifier.issue12en_US
dc.identifier.pmid1493945en_US
dc.identifier.startpage704en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12395/16139
dc.identifier.volume15en_US
dc.identifier.wosWOS:A1992KJ34600004en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakPubMeden_US
dc.institutionauthorYeksan, M.
dc.institutionauthorTürk, S.
dc.institutionauthorPolat, M.
dc.institutionauthorÇığlı, A.
dc.institutionauthorErdoğan, Y.
dc.language.isoenen_US
dc.publisherSAGE PUBLICATIONS LTDen_US
dc.relation.ispartofThe International Journal of Artificial Organen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.selcuk20240510_oaigen_US
dc.subjectCalcitriolen_US
dc.subjectHemodialysisen_US
dc.subjectLipidsen_US
dc.titleEffects of 1,25 (OH)2 0 3 Treatment on Lipid Levels in Uremic Hemodialysis Patientsen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
yeksan1992.pdf
Boyut:
326.25 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Makale Dosyası
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Tıbbi Biyokimya/Makale Koleksiyonu